Mostrar el registro sencillo del ítem

Respuesta del uso de toxina botulínica en paciente con cefalea crónica diaria: migraña y tipo tensión en el Hospital Militar Central en el periodo del 2010 al 2014

dc.contributor.advisorMeza Gaviria, Antoniospa
dc.contributor.advisorGuzman Molano, Luisa fernandaspa
dc.contributor.authorUnda McFarlane, Maria Catalina
dc.contributor.authorVargas Osorio, Juliana
dc.coverage.spatialMedicinaspa
dc.date.accessioned2016-02-01T22:50:50Z
dc.date.accessioned2019-12-30T19:04:46Z
dc.date.available2016-02-01T22:50:50Z
dc.date.available2019-12-30T19:04:46Z
dc.date.issued2015-08-13
dc.identifier.urihttp://hdl.handle.net/10654/7274
dc.description.abstractEstudio descriptivo, de tipo observacional longitudinal en el que se evaluó la respuesta de uso de toxina en pacientes con cefalea crónica diaria, tratados en la clínica de toxina del Hospital Militar Central durante el periodo 2010 a 2014. La respuesta al uso de toxina se evaluó mediante escala visual análoga del dolor (EVA), días de dolor y horas de dolor por día; antes y después de la aplicación de toxina. También se evaluó la ocurrencia de eventos adversosspa
dc.formatpdfspa
dc.language.isospaspa
dc.publisherUniversidad Militar Nueva Granadaspa
dc.titleRespuesta del uso de toxina botulínica en paciente con cefalea crónica diaria: migraña y tipo tensión en el Hospital Militar Central en el periodo del 2010 al 2014spa
dc.typeinfo:eu-repo/semantics/bachelorThesisspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.subject.lembTOXINAS BOTULINICASspa
dc.subject.lembTOXINAS BACTERIANASspa
dc.subject.lembCEFALALGIAspa
dc.subject.lembMIGRAÑAspa
dc.publisher.departmentFacultad de Medicinaspa
dc.type.localTrabajo de gradospa
dc.description.abstractenglishWe evaluated the response of botulinum toxin in patients with chronic headache, migraine and tension type in the Mikitary hospital. We observed a reduction in the duration time a severity.eng
dc.title.translatedResponse of botulinum toxin in patients with chronic headache tension a migraine type in the Military Hospital of Bogotá in the period of 2010 to 2014spa
dc.subject.keywordsChronic daily headachespa
dc.subject.keywordsBotulinum Toxinspa
dc.publisher.programNeurologíaspa
dc.creator.degreenameEspecialista en Neurologíaspa
dc.relation.references1. Ahmed F, Parthasarathy R, Khalil. Chronic daily headaches. Ann Indian Acad Neurol. 2012 Aug;15:40-50.spa
dc.relation.references3. Dodick DW, Mauskop A. Botulinum toxin type A for profilaxis chronic headache. Headache 2005, 45:315-324.spa
dc.relation.references2. Midgette LA, Scher AI. The epidemiology of chronic daily headache. Curr Pain Headache Rep.2009;13: 59-63.spa
dc.relation.references4. Dodick DW. Chronic daily headaches . New England Journal, 2006;354:158-65.spa
dc.relation.references5. Shilpa P.S., Rashna K. Botulinum toxin: the mifdas touch. J Nat Sci Biol Med. 2014 Jan-Jun; 5(1): 8–14.spa
dc.relation.references6. Ahmed F, Parthasarathy R, Khalil M. Chronic daily headaches. Ann Indian Acad Neurol .2012;15:40-50spa
dc.relation.references7. Carod-Artal FJ, Irimia P, Ezpeleta D. chronic migraine: definition, epidemiology, risk factors and treatment. RevNeurol 2012; 54 (10): 629-637spa
dc.relation.references8. Pradilla G, Muñoz Cerón F. Dolor de Cabeza: epidemiología e impacto. Acta Neurol Colomb 2013;29:3-10.spa
dc.relation.references9. Sobrino F. Cefalea crónica diaria. Acta Neurol Colomb 2013;29:96-106spa
dc.relation.referencesWard T. Migraine Diagnosis and Pathophysiology, Continuum Lifelong Learning Neurol 2012;18:753–763spa
dc.relation.references11. Volcy M. Pathophysiology of chronic migraine. Acta Neurol Colomb 2013;29:25-30.spa
dc.relation.references12. Kaniecki RG. Tension type headache, Continuum Lifelong Learning Neurol 2012;823–834spa
dc.relation.references13. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 suppl 1:9-160spa
dc.relation.references14. Halker RB, Hastriter EV, Dodick DW. Chronic daily headache: an evidence-based and systematic approach to a challenging problem. Neurology. 2011;76(7 suppl 2): S37-S43spa
dc.relation.referencesYancey JR, Maj MC. Chronic Daily Headache: Diagnosis and Management. Am Fam Physician. 2014;89(8):642-648spa
dc.relation.references16. Dodick DW. Clinical practice. Chronic daily headache [published correction appears in N Engl J Med. 2006;354(8):884]. N Engl J Med. 2006;354(2):158-165spa
dc.relation.references17. Matharu MS, Goadsby PJ. Trigeminal autonomic cephalgias. J Neurol Neurosurg Psychiatry. 2002;72 suppl 2:ii19-ii26spa
dc.relation.references18. Goadsby PJ, Boes C. Chronic daily headache. J Neurol Neurosurg Psychiatry. 2002;72 suppl 2:ii2-ii5spa
dc.relation.references19. Jull G, Trott P, Potter H, et al. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine (Phila Pa 1976). 2002;27(17): 1835-1843spa
dc.relation.references20. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;(1):CD001218spa
dc.relation.references21. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev. 2009;(1):CD007587spa
dc.relation.references22. Devineni T, Blanchard EB. A randomized controlled trial of an internet-based treatment for chronic headache. Behav Res Ther. 2005;43(3):277-292spa
dc.relation.references23. Nash JM, Park ER, Walker BB, Gordon N, Nicholson RA. Cognitive-behavioral group treatment for disabling headache. Pain Med. 2004;5(2):178-186spa
dc.relation.references24. Thorn BE, Pence LB, Ward LC, et al. A randomized clinical trial of targeted cognitive behavioral treatment to reduce catastrophizing in chronic headache sufferers. J Pain. 2007;8:938-949spa
dc.relation.references25. Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2014 Oct;34:944spa
dc.relation.references26. Couch JR. Amitriptyline Versus Placebo Study Group. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache. 2011;51:33-51spa
dc.relation.references27. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005spa
dc.relation.references28. Saper JR, Lake AE III, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache. 2002;42:470-482spa
dc.relation.references29. Lake III AE. Chronic daily headache: new treatment strategies. Presented at the World Congress of Neurology (WCN), November 15–17, 2002spa
dc.relation.references30. Spira PJ, Beran RG; Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic dailyspa
dc.relation.references31. Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia. 2008;28:585-597spa
dc.relation.references32. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Dabatase Syst Rev. 2004spa
dc.relation.references33. Holroyd KA, O’Donnell FJ, Stensland M, et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 2001;285:2208–15spa
dc.relation.references34. Drucker P, Tepper S. Daily sumatriptan for detoxification from rebound. Headache 1998; 38:687–90.spa
dc.relation.references35. Dodick, D.W., Turkel, C.C., DeGryse, R.E., Aurora, S.K., Silberstein, S.D., Lipton, R.B., Diener, H.C., Brin, M.F., PREEMPT Chronic Migraine Study Group, 2010. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921–936spa
dc.relation.references36. Kerner, J., 1822. Das Fettgift oder die Fettsaure und ihre Wirkungen auf den thierischen Organismus, ein Beytrag zur Untersuchung des in verdorbenen Wursten giftig wirkenden Stoffes. Cotta, Stuttgart; Tu¨ bingenspa
dc.relation.references37. Erbguth, F.J. From poison to remedy: the chequered history of botulinum toxin. J. Neural Transm. 2008; 115: 559–565spa
dc.relation.references38. Barnes, M. Botulinum toxin-mechanisms of action and clinical use in spasticity. J. Rehabil. Med. 2008;115: 56–59.spa
dc.relation.references39. Thenganatt, M.A., Fahn, S. Botulinum toxin for the treatment of movement disorders. Curr. Neurol. Neurosci. Rep. 2012; 12: 399–409spa
dc.relation.references40. Ivica M, Zdravko L. Botulinum toxin A, brain and pain. Progress in Neurobiology. 2014; 119–120spa
dc.relation.references41. Grumelli C., Corradini I., Matteoli M., Verderio C. Intrinsic calcium dynamics control botulinum toxin A susceptibility in distinct neuronal populations. Cell Calcium, 2010; 47, 419–424spa
dc.relation.references42. Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012; 307:1736-1745spa
dc.relation.references43. Straube A, Empl M, Ceballos-Baumann A, Tölle T, Stefenelli U, Pfaffenrath V. Pericranial injection of botulinum toxin type A (Dysport) fortension type headache - a multicentre,double-blind, randomized, placebo-controlled study. Eur J Neurol -2008; 15: 205-13spa
dc.relation.references44. Erdemoglu AK. The long-term efficacy and safety of botulinum toxin in refractory chronic tension type headache. J Headache Pain .2007; 8: 294-300spa
dc.relation.references45. Hamdy SM. Botulinum toxin: could it be an effective treatment for chronic tension type headache. J Headache Pain .2009; 10: 27-34spa
dc.relation.references46. Harden RN. Botulinum toxin a in the treatment of chronic tension type headache with cervical myofascial trigger points: aspa
dc.relation.references47. Karadaay O. Botulinum neuro-toxin type-A in the treatment of chronic tension type headache associated with pericranial tenderness]. - Agri - 01-JAN-2012; 24(1): 9-14spa
dc.relation.references48. Blumenfeld AM1, Schim JD, Chippendale TJ. Botulinum toxin type A and divalproex sodiumfor proplylatic treatment of episodic or chronic migraine. Headache 2008; 48: 210-220spa
dc.relation.references49. Mathew NT, Frahan JS.A double blind coparision of BOTOX and topiramato. Headache 2009; 49: 1466-1478spa
dc.relation.references50. Jakubowski M et al. Exploding vs inplonding headache in migraine prophylaxis with botulinumtoxin A. Pain 2006; 105:286-295spa
dc.subject.proposalcefalea cronica diariaspa
dc.subject.proposaltoxina bolulinicaspa


Archivos en el ítem

Thumbnail
Nombre:
Documento final PROTOCOLO.pdf
Tamaño:
761.3Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem